Reaction Details Report a problem with these data
Target
Reverse transcriptase
Ligand
BDBM50450813
Substrate
n/a
Meas. Tech.
ChEMBL_541098 (CHEMBL1034081)
IC50
380±n/a nM
Citation
 Boojamra, CG; Parrish, JP; Sperandio, D; Gao, Y; Petrakovsky, OV; Lee, SK; Markevitch, DY; Vela, JE; Laflamme, G; Chen, JM; Ray, AS; Barron, AC; Sparacino, ML; Desai, MC; Kim, CU; Cihlar, T; Mackman, RL Design, synthesis, and anti-HIV activity of 4'-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors. Bioorg Med Chem 17:1739-46 (2009) [PubMed]  Article 
Target
Name:
Reverse transcriptase
Synonyms:
n/a
Type:
Protein
Mol. Mass.:
29598.37
Organism:
Human immunodeficiency virus 1
Description:
Q9WKE8
Residue:
254
Sequence:
PISPITVPVKLKPGMDGPKVKQWPLTEEKIKALTEICTEMEKEGKIEKIGPENPYNTPVFAIKKKDSTKWRKVVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIEQHRAKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVN
  
Inhibitor
Name:
BDBM50450813
Synonyms:
Atripla | CHEBI:63625 | GS-1275 | PMP-A | Tenofovir | Truvada
Type:
Small organic molecule
Emp. Form.:
C9H14N5O4P
Mol. Mass.:
287.2123
SMILES:
C[C@H](Cn1cnc2c(N)ncnc12)OCP(O)(O)=O |r|
Structure:
Search PDB for entries with ligand similarity: